Focal Therapy for Prostate Cancer: Insights from Dr. Arvin George on Its Promising Future
Key Points from the LUGPA Presentation
Table of Contents
Dr. Arvin George discussed focal therapy in his presentation titled “Focal therapy: Killing cancer not the prostate.” He focused on selecting appropriate patients for treatment, reviewing achievable outcomes, and addressing follow-up strategies. He also highlighted future directions in the focal therapy field.
Evolution of Focal Therapy Adoption
Over the last decade, there has been significant progress in the adoption of focal therapy. Initially met with skepticism, the outlook has shifted to optimism. More community-based practitioners are offering these treatments, and academic programs that once hesitated are now engaging in the process. Publications and discussions in professional circles are increasing, demonstrating the field’s growth.
Background on Water Vapor Thermal Therapy
Dr. George is leading a trial on water vapor thermal therapy for prostate cancer, an approach already familiar to urologists due to its use in treating BPH with Rezum. This treatment employs steam and convection to destroy prostate tissue. Enhanced directional delivery and imaging guidance are recent advancements that optimize the treatment’s precision.
Goals of the Study
The study is unique, as it is among the first in the ablative space approved by the FDA. It aims to demonstrate that the technology can effectively destroy prostate tissue. Additionally, it evaluates the safety of the treatment and aims to eliminate specific cancer grades within three years, with patient follow-ups culminating in a final biopsy.
Updates on the PRESERVE Trial
Dr. George is also leading the PRESERVE trial, which uses irreversible electroporation (IRE) for prostate cancer. Results are expected soon, pending FDA review. The trial will provide specific data on IRE’s effectiveness in prostate tissue ablation, which could expand its use in patient treatments.
Future Directions in Focal Therapy
Emerging technologies in focal therapy show promise for advancing treatment options. The landscape is changing quickly as new methods are developed and adopted, aiming to improve cancer care and patient outcomes.